Status:
COMPLETED
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Lead Sponsor:
University of Pittsburgh
Conditions:
Infection
E Coli Infections
Eligibility:
All Genders
Brief Summary
The purpose of this study is to review patients with E. coli infections at the University of Pittsburgh Medical Center (UPMC) from September 1, 2006 to August 31, 2007 to determine if these infections...
Detailed Description
The following variables will be followed: age, sex, occupation, hospital location at the time of positive culture (ER, medical ward, ICU, etc.), prior hospitalization or nursing home admission, receip...
Eligibility Criteria
Inclusion
- All patients with E. coli, Klebsiella species, and Proteus species infections during the time period of the study will be reviewed. A community-associated E. coli isolate will be defined as one which was recovered from a clinical culture from a patient at UPMC who had no established risk factors for infection with an antibiotic resistant organism. Established risk factors are defined as:
- Isolation of the organism two or more days after admission for hospitalization OR
- History of hospitalization, surgery, dialysis, or residence in a long-term care facility within one year before the culture date OR
- The presence of an indwelling catheter or percutaneous medical device (eg, tracheostomy tube, gastrostomy tube, or Foley catheter) at the time of the culture OR
- Previous isolation of an antibiotic resistant organism.
Exclusion
- None
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00363220
Start Date
August 1 2006
End Date
December 1 2015
Last Update
December 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213